Pursuit Vascular raises $1.6 million in a debt and securities offering for its ClearGuard catheter infection-reducing device.
Pursuit Vascular said it raise approximately $1.6 million in a debt and securities offering to a group of 33 unnamed investors.
Based in Maple Grove, Minn., Pursuit markets a device called ClearGuard that's designed to kill bacteria and fungi in hemodialysis catheters. The product, an antimicrobial fluid lock, received FDA approval in late 2013.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1D1OWHZ
Cap comentari:
Publica un comentari a l'entrada